Search Results 411-420 of 19204 for creatinine

  1. XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia - Mayo Clinic

    < 1.5 × ULN. 2. Calculated creatinine clearance ≥ 40 mL/min (calculated by Cockcroft-Gault formula) for subjects with creatinine levels above institutional ...

  2. ... CREATININE CLEARANCE,145,154.00, 301000185,HC CREATININE OTHER SOURCE,95,101.00, 301000187,HC CRMP 5 WESTERN BLOT,414,#N/A,439.00 301000188,HC ...

  3. Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) - Mayo Clinic

    Serum creatinine ≤ 2.0 × ULN; OR; Creatinine clearance > 40 mL/min based on the Cockcroft-Gault glomerular filtration rate estimation: (140 – Age) × (Weight ...

  4. Consortium improves cardiogenic shock outcomes across southeast - Mayo Clinic

    For smaller hospitals, this includes simple steps such as teaching teams to check three key labs — lactate, creatinine and liver enzymes — whenever a patient is ...

  5. Chronic kidney disease - Doctors and departments - Mayo Clinic

    Associated Procedures · Blood urea nitrogen (BUN) test · Creatinine test · Deceased-donor kidney transplant · Hemodialysis · Kidney biopsy · Kidney transplant · Living ...

  6. Chronic kidney disease - Doctors and departments - Mayo Clinic

    Creatinine test · Deceased-donor kidney transplant · Hemodialysis · Kidney biopsy · Kidney transplant · Living-donor kidney transplant · Minimally invasive ...

  7. Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients - Mayo Clinic

    Creatinine < 1.3 mg/dL; if Creatinine is > 1 mg/dL the Creatinine clearance should be > 40 mL/min as calculated using the Cockcroft-Gault formula. Women ...

  8. A Study to Evaluate the Effectiveness and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients - Mayo Clinic

    At least 25% rise in serum creatinine compared to last individual value taken prior to the AMR. Patients with delayed graft function and AMR within 10 days ...

  9. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    Serum creatinine =< 1.5 X institutional ULN and creatinine clearance >= 60 ml/min NOTE: Creatinine clearance must be calculated using the Cockcroft-Gault ...

  10. Visionary Study: Phase 3 Trial Of Sibeprenlimab In Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    other protocol requirements. - Screening urine protein/creatinine ratio (uPCR) ≥ 0.75 g/g or urine protein ≥ 1.0 g/day. - eGFR ≥ 30 mL/min/1.73 m2, (for ...